Answers are grounded in this paper and cite their sources.
One hundred and eighty-eight patients with inoperable or unresectable bronthogenic carcinoma, classified by cell type and extent of disease, were randomly allocated to radiotherapy alone or to radiotherapy plus 5-FU. Results of therapy, evaluated primarily by survival rates, revealed no significant improvement by the addition of 5-FU. For example, the survival rates at 12 months for patients with squamous cell carcinoma were 32% after radiotherapy alone and 36% after radiotherapy plus 5-FU. Comparable survival rates for patients with adenocarcinoma were 42% and 60%; for patients with small cell carcinoma, 19% and 23%; and for patients with large cell undifferentiated carcinoma, 31% and 28%. Our data reveal that the regimen of 5-FU and radiotherapy is not significantly more effective than radiotherapy alone in the treatment of inoperable or unresectable bronchogenic carcinoma.
No takes yet. Share an insight, caveat, or question.
Carr et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: